CClinicalTrials.gg
Status unknownNCT03136276Updated May 2, 2017

One Year Clinical Evaluation of IPS Empress CAD Versus Polished Celtra Duo Ceramic Laminate Veneers

An interventional study of IPS Empress CAD and polished Celtra Duo in Tooth Discoloration, Tooth Fractures and Diastema, sponsored by Cairo University. Status unknown. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2017-05-02.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2017), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

When restoring teeth with IPS Empress laminate veneers, fracture of restorations may occur. So, material with higher mechanical properties is required. Celtra Duo is a new material with glass ceramics infiltrated by 10% zirconia particles which increase the fracture resistance of the material.

02

Conditions studied

  • Tooth Discoloration
  • Tooth Fractures
  • Diastema
03

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

All subjects are required to be:

  1. From 18-50 years old, be able to read and sign the informed consent document.
  2. Have no active periodontal or pulpal diseases, have teeth with good restorations
  3. Psychologically and physically able to tolerate conventional dental procedures
  4. Patients with teeth problems indicated for laminate veneer:

    1. Discoloration
    2. Fracture not involving more than 50% enamel loss
    3. Mild malposition
    4. Diastema
    5. Enamel fluorosis
    6. Stained or defective restorations
  5. Able to return for follow-up examinations and evaluation

Exclusion criteria

Exclusion Criteria:

  1. Patient with post and core endodontically treated teeth
  2. Patient with fractured teeth of more than 50% enamel loss
  3. Patients with poor oral hygiene and motivation
  4. Pregnant women's
  5. Patients in the growth stage with partially erupted teeth
  6. Psychiatric problems or unrealistic expectations
  7. Lack of opposing dentition in the area of interest
  8. Patients involved in contact sports
  9. Teeth with deep discoloration
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
36 participants (estimated)

Study arms

  • Active comparator
    IPS Empress CAD

    Leucite Based glass Ceramics which is etchable ceramics and proved to have good success rate if used for laminate veneers

    Other: IPS Empress CAD

  • Experimental
    polished Celtra Duo

    Zirconia reinforced lithium silicate, it is a recent material with glass ceramics enriched with 10% zirconia that offers high strength properties

    Other: polished Celtra Duo

Interventions

  • OtherIPS Empress CAD

    standard etchable glass ceramics

    Also known as: leucite based glass ceramics

  • Otherpolished Celtra Duo

    new glass ceramic material

    Also known as: zirconia reinforced lithium silicate (ZLS)

05

What researchers measure

Primary outcomes

  1. Fracture

    number of fractured laminates

    Time frame: 1 year

06

Study locations

No study locations are listed for this record.

07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03136276
Lead sponsor
Cairo University
Responsible party
Hayat Ibrahim Mahrous Ibrahim (assisstant lecturer, fixed prosthodontic department, faculty of oral and dental medicine, Cairo University) — Principal investigator
First posted
May 2, 2017
Start date
Jul 2017 (estimated)
Primary completion
Jul 2018 (estimated)
Completion
Sep 2018 (estimated)
Last update
May 2, 2017

Study contacts

Hayat El-Banna, M.D.s
Contact
hayat.elbanna@dentistry.cu.edu.eg
01001248734
Jylan EL-Guindy
Contact

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion